Table 1.
Diagnosis | PV | PV | PV | PMF | PMF | PMF | ET | ET | ET | nBM | nBM | nBM | nBM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient # | 18 | 06 | 30 | 20 | 29 | 16 | 34 | 02 | 23 | 46 | 48 | 50 | 51 |
Megakaryocytes | ++ | ++ | ++ | + | ++ | ++ | ++ | ++ | + | ++ | ++ | ++ | ++ |
Myeloid prog. | + | + | + | + | + | + | + | +/− | +/− | + | +(+) | + | + |
Neutrophil gran. | + | + | +/− | + | + | + | + | − | +/− | +/− | + | − | +/− |
Eosinophil gran. | − | − | − | − | − | − | − | − | n.a. | − | − | n.a. | n.a. |
Erythroid prog. | − | − | − | − | − | − | − | − | − | − | − | − | − |
Score: ++, strong expression in most cells; +, clear expression in the majority of cases; +/-, expressed in subsets of cells or only weakly expressed; −, no expression (below detection limit). Abbreviations: CM, cutaneous mastocytosis; ET, essential thrombocythemia; gran., granulocytes; MPN, myeloproliferative neoplasm; n.a., not analyzed (no cells found by microscopy); nBM, normal bone marrow; NHL, Non-Hodgkin lymphoma; PMF, primary myelofibrosis; prog., progenitors; PV, polycythemia vera.